1. Home
  2. ICCC vs VTSI Comparison

ICCC vs VTSI Comparison

Compare ICCC & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • VTSI
  • Stock Information
  • Founded
  • ICCC 1982
  • VTSI 1993
  • Country
  • ICCC United States
  • VTSI United States
  • Employees
  • ICCC N/A
  • VTSI N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • ICCC Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • ICCC 47.4M
  • VTSI 45.2M
  • IPO Year
  • ICCC 1987
  • VTSI N/A
  • Fundamental
  • Price
  • ICCC $5.20
  • VTSI $4.67
  • Analyst Decision
  • ICCC
  • VTSI Strong Buy
  • Analyst Count
  • ICCC 0
  • VTSI 2
  • Target Price
  • ICCC N/A
  • VTSI $13.00
  • AVG Volume (30 Days)
  • ICCC 22.3K
  • VTSI 67.4K
  • Earning Date
  • ICCC 05-14-2025
  • VTSI 05-12-2025
  • Dividend Yield
  • ICCC N/A
  • VTSI N/A
  • EPS Growth
  • ICCC N/A
  • VTSI N/A
  • EPS
  • ICCC N/A
  • VTSI 0.12
  • Revenue
  • ICCC $26,493,169.00
  • VTSI $26,350,819.00
  • Revenue This Year
  • ICCC N/A
  • VTSI N/A
  • Revenue Next Year
  • ICCC N/A
  • VTSI $22.35
  • P/E Ratio
  • ICCC N/A
  • VTSI $38.92
  • Revenue Growth
  • ICCC 51.63
  • VTSI N/A
  • 52 Week Low
  • ICCC $3.34
  • VTSI $3.57
  • 52 Week High
  • ICCC $5.82
  • VTSI $17.68
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.84
  • VTSI 56.02
  • Support Level
  • ICCC $5.01
  • VTSI $4.23
  • Resistance Level
  • ICCC $5.72
  • VTSI $4.61
  • Average True Range (ATR)
  • ICCC 0.18
  • VTSI 0.32
  • MACD
  • ICCC -0.04
  • VTSI 0.09
  • Stochastic Oscillator
  • ICCC 37.50
  • VTSI 81.60

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: